S&P 500
(0.41%) 5 328.52 points
Dow Jones
(-0.34%) 39 537 points
Nasdaq
(0.96%) 16 963 points
Oil
(1.13%) $78.45
Gas
(2.15%) $2.90
Gold
(-1.10%) $2 366.50
Silver
(-1.64%) $30.98
Platinum
(-0.23%) $1 047.30
USD/EUR
(-0.26%) $0.921
USD/NOK
(-0.79%) $10.61
USD/GBP
(-0.14%) $0.785
USD/RUB
(0.34%) $90.50

Realtime updates for Pfizer Inc [PFE]

Exchange: NYSE Sector: Healthcare Industry: Drug Manufacturersā€”General
Last Updated23 May 2024 @ 09:39

-1.57% $ 29.14

Live Chart Being Loaded With Signals

Commentary (23 May 2024 @ 09:39):
Profile picture for Pfizer Inc

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands...

Stats
Today's Volume 3.12M
Average Volume 42.69M
Market Cap 165.10B
EPS $0 ( 2024-05-01 )
Next earnings date ( $0 ) 2024-07-30
Last Dividend $0.420 ( 2024-05-09 )
Next Dividend $0 ( N/A )
P/E -582.70
ATR14 $0.0280 (0.10%)
Insider Trading
Date Person Action Amount type
2024-05-15 Damico Jennifer B. Buy 49 Phantom Stock Units SSP
2024-05-15 Bourla Albert Buy 18 Phantom Stock Units SSP
2024-04-30 Damico Jennifer B. Buy 55 Phantom Stock Units SSP
2024-04-30 Bourla Albert Buy 20 Phantom Stock Units SSP
2024-04-25 Quincey James Buy 8 116 Phantom Stock Units
INSIDER POWER
71.10
Last 100 transactions
Buy: 4 322 829 | Sell: 735 491

Volume Correlation

Long: 0.34 (neutral)
Short: -0.53 (weak negative)
Signal:(30.651) Neutral

Pfizer Inc Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Pfizer Inc Correlation - Currency/Commodity

The country flag 0.50
( weak )
The country flag 0.36
( neutral )
The country flag 0.00
( neutral )
The country flag 0.39
( neutral )
The country flag 0.00
( neutral )
The country flag 0.02
( neutral )

Pfizer Inc Financials

Annual 2023
Revenue: $58.50B
Gross Profit: $29.28B (50.06 %)
EPS: $0.380
FY 2023
Revenue: $58.50B
Gross Profit: $29.28B (50.06 %)
EPS: $0.380
FY 2022
Revenue: $100.33B
Gross Profit: $65.99B (65.77 %)
EPS: $5.59
FY 2021
Revenue: $81.29B
Gross Profit: $50.47B (62.08 %)
EPS: $3.92

Financial Reports:

No articles found.

Pfizer Inc Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0.400
(N/A)
$0.400
(N/A)
$0.410
(N/A)
$0.410
(N/A)
$0.410
(N/A)
$0.410
(N/A)
$0.420
(N/A)
$0.420
(N/A)
$0
(N/A)
$0
(N/A)

Pfizer Inc Dividend Information - Dividend Knight

Dividend Sustainability Score: 2.91 - low (50.00%) | Divividend Growth Potential Score: 0.677 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.00316 1972-08-29
Last Dividend $0.420 2024-05-09
Next Dividend $0 N/A
Payout Date 2024-06-14
Next Payout Date N/A
# dividends 208 --
Total Paid Out $26.89 --
Avg. Dividend % Per Year 3.19% --
Score 4.31 --
Div. Sustainability Score 2.91
Div.Growth Potential Score 0.677
Div. Directional Score 1.792 --
Next Divdend (Est)
(2024-07-01)
$0.423 Estimate 74.85 %
Dividend Stability
1.00 Excellent
Dividend Score
4.31
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield
1972 $0.00731 0.90%
1973 $0.0138 1.60%
1974 $0.0156 1.83%
1975 $0.0160 2.52%
1976 $0.0170 3.03%
1977 $0.0196 3.44%
1978 $0.0231 4.27%
1979 $0.0261 3.98%
1980 $0.0285 3.84%
1981 $0.0316 3.01%
1982 $0.0364 3.50%
1983 $0.0460 3.43%
1984 $0.0524 3.66%
1985 $0.0584 3.65%
1986 $0.0648 3.27%
1987 $0.0712 2.91%
1988 $0.0792 4.13%
1989 $0.0868 3.81%
1990 $0.0948 3.37%
1991 $0.104 3.29%
1992 $0.117 1.77%
1993 $0.133 2.32%
1994 $0.149 2.77%
1995 $0.164 2.74%
1996 $0.190 1.93%
1997 $0.215 1.66%
1998 $0.240 1.00%
1999 $0.291 0.75%
2000 $0.342 1.13%
2001 $0.416 0.95%
2002 $0.492 1.30%
2003 $0.568 1.90%
2004 $0.644 1.91%
2005 $0.720 2.87%
2006 $0.912 4.04%
2007 $1.100 4.41%
2008 $1.216 5.59%
2009 $0.760 4.39%
2010 $0.684 3.81%
2011 $0.760 4.53%
2012 $0.836 4.01%
2013 $0.912 3.71%
2014 $0.988 3.42%
2015 $1.064 3.58%
2016 $1.140 3.76%
2017 $1.216 3.88%
2018 $1.292 3.74%
2019 $1.368 3.33%
2020 $1.444 3.89%
2021 $1.560 4.24%
2022 $1.600 2.82%
2023 $1.640 3.20%
2024 $0.840 2.83%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NYSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
LOMA Dividend King 2023-06-30 Quarterly 2 5.23% 8.53
ACP Dividend Royal 2024-05-22 Monthly 14 11.88% 8.50
PVL Dividend Royal 2023-11-15 Monthly 14 9.37% 8.50
ACV Dividend Royal 2024-06-13 Monthly 10 10.19% 8.50
ARR Dividend Royal 2024-05-14 Monthly 15 11.08% 8.50
AFG Dividend Royal 2024-04-12 Bi-Monthly 39 9.39% 8.06
JPT Dividend King 2023-11-02 Monthly 8 4.19% 8.05
VCIF Dividend Royal 2023-08-18 Monthly 6 8.05% 8.02
EDI Dividend Royal 2023-12-07 Monthly 13 8.85% 7.94
AIO Dividend Royal 2024-06-13 Monthly 6 9.48% 7.86

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-0.005371.500-0.107-0.161[0 - 0.5]
returnOnAssetsTTM-0.001341.200-0.0446-0.0536[0 - 0.3]
returnOnEquityTTM-0.003141.500-1.146-1.719[0.1 - 1]
payoutRatioTTM-31.47-1.000-10.0010.00[0 - 1]
currentRatioTTM1.0470.8009.767.81[1 - 3]
quickRatioTTM0.5660.800-1.377-1.102[0.8 - 2.5]
cashRatioTTM0.01781.500-1.012-1.519[0.2 - 2]
debtRatioTTM0.315-1.5004.76-7.14[0 - 0.6]
interestCoverageTTM0.6641.000-0.865-0.865[3 - 30]
operatingCashFlowPerShareTTM1.5162.009.4910.00[0 - 30]
freeCashFlowPerShareTTM0.9032.009.5510.00[0 - 20]
debtEquityRatioTTM0.754-1.5006.99-10.00[0 - 2.5]
grossProfitMarginTTM0.4891.0005.195.19[0.2 - 0.8]
operatingProfitMarginTTM0.03231.000-1.354-1.354[0.1 - 0.6]
cashFlowToDebtRatioTTM0.1231.000-0.426-0.426[0.2 - 2]
assetTurnoverTTM0.2490.800-1.672-1.338[0.5 - 2]
Total Score2.91

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-565.701.000-10.000[1 - 100]
returnOnEquityTTM-0.003142.50-0.737-1.719[0.1 - 1.5]
freeCashFlowPerShareTTM0.9032.009.7010.00[0 - 30]
dividendYielPercentageTTM5.611.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM1.5162.009.4910.00[0 - 30]
payoutRatioTTM-31.471.500-10.0010.00[0 - 1]
pegRatioTTM-39.921.500-10.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1561.0008.610[0.1 - 0.5]
Total Score0.677

Pfizer Inc Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Pfizer Inc

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators